Abstract

Thymidine-analogue nucleoside reverse transcriptase inhibitors (NRTIs) are the biggest culprits when it comes to lipodystrophy induced by antiretroviral therapy. However, patients on various thymidine-sparing regimens can also develop the condition, with risks and patterns of illness that are quite unpredictable. Seeking to clarify this murky area, researchers conducted a substudy within ACTG 5202, a clinical trial in which antiretroviral-naive HIV-infected adults were randomized to one …

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.